Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.
Identifieur interne : 002635 ( PubMed/Corpus ); précédent : 002634; suivant : 002636Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.
Auteurs : Hiroyuki Kogaki ; Yoshiaki Uchida ; Nobuyuki Fujii ; Yoshihiro Kurano ; Kazushige Miyake ; Yasuji Kido ; Hiroaki Kariwa ; Ikuo Takashima ; Hiko Tamashiro ; Ai-Ee Ling ; Masahisa OkadaSource :
- Journal of clinical laboratory analysis [ 0887-8013 ] ; 2005.
English descriptors
- KwdEn :
- Animals, Antibodies, Monoclonal (immunology), Chlorocebus aethiops, Chromatography, Coronavirus (immunology), DNA, Recombinant, Escherichia coli, Immunoenzyme Techniques (instrumentation), Immunoenzyme Techniques (methods), Mice, Nucleocapsid (analysis), Nucleocapsid (immunology), Reproducibility of Results, Sensitivity and Specificity, Severe Acute Respiratory Syndrome (virology), Time Factors, Vero Cells.
- MESH :
- chemical , immunology : Antibodies, Monoclonal.
- analysis : Nucleocapsid.
- immunology : Coronavirus, Nucleocapsid.
- instrumentation : Immunoenzyme Techniques.
- methods : Immunoenzyme Techniques.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Chlorocebus aethiops, Chromatography, DNA, Recombinant, Escherichia coli, Mice, Reproducibility of Results, Sensitivity and Specificity, Time Factors, Vero Cells.
Abstract
A novel severe acute respiratory syndrome-associated coronavirus (SARS-CoV) has been discovered. The detection of both antigens and antibodies in SARS-CoV from human specimens with suspected SARS plays an important role in preventing infection. We developed a novel rapid immunochromatographic test (RICT) based on the sandwich format enzyme immunoassay (EIA) with an all-in-one device for detecting the native nucleocapsid antigen (N-Ag) of SARS-CoV using monoclonal antibodies (MoAbs), which we produced by immunizing recombinant N-Ag to mice. RICT is a qualitative assay for respiratory aspirates and serum specimens. With this assay, a positive result can be judged subjectively by the appearance of a blue line on the device 15 min after the sample is applied. RICT with several pairs of MoAbs showed a high sensitivity for the detection of recombinant N-Ag as well as viral N-Ag of SARS-CoV. rSN122 and rSN21-2 were the best MoAbs for immobilized antibody and enzyme labeling, respectively. With regard to analytical sensitivity, RICT detected N-Ag at 31 pg/mL for recombinant N-Ag, and at 1.99 x 10(2) TCID(50)/mL for SARS-CoV. The specificity of RICT was 100% when 150 human sera and 50 nasopharyngeal aspirates (NSPs) were used. RICT based on an EIA using the rSN122/rSN21-2 pair is a sensitive, specific, and reliable rapid assay for detecting N-Ag in SARS-CoV treated with either heat or Triton X-100.
DOI: 10.1002/jcla.20070
PubMed: 16025480
Links to Exploration step
pubmed:16025480Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.</title><author><name sortKey="Kogaki, Hiroyuki" sort="Kogaki, Hiroyuki" uniqKey="Kogaki H" first="Hiroyuki" last="Kogaki">Hiroyuki Kogaki</name><affiliation><nlm:affiliation>Research and Development Division, Fujirebio Inc., Tokyo, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Uchida, Yoshiaki" sort="Uchida, Yoshiaki" uniqKey="Uchida Y" first="Yoshiaki" last="Uchida">Yoshiaki Uchida</name></author><author><name sortKey="Fujii, Nobuyuki" sort="Fujii, Nobuyuki" uniqKey="Fujii N" first="Nobuyuki" last="Fujii">Nobuyuki Fujii</name></author><author><name sortKey="Kurano, Yoshihiro" sort="Kurano, Yoshihiro" uniqKey="Kurano Y" first="Yoshihiro" last="Kurano">Yoshihiro Kurano</name></author><author><name sortKey="Miyake, Kazushige" sort="Miyake, Kazushige" uniqKey="Miyake K" first="Kazushige" last="Miyake">Kazushige Miyake</name></author><author><name sortKey="Kido, Yasuji" sort="Kido, Yasuji" uniqKey="Kido Y" first="Yasuji" last="Kido">Yasuji Kido</name></author><author><name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name></author><author><name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name></author><author><name sortKey="Tamashiro, Hiko" sort="Tamashiro, Hiko" uniqKey="Tamashiro H" first="Hiko" last="Tamashiro">Hiko Tamashiro</name></author><author><name sortKey="Ling, Ai Ee" sort="Ling, Ai Ee" uniqKey="Ling A" first="Ai-Ee" last="Ling">Ai-Ee Ling</name></author><author><name sortKey="Okada, Masahisa" sort="Okada, Masahisa" uniqKey="Okada M" first="Masahisa" last="Okada">Masahisa Okada</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16025480</idno><idno type="pmid">16025480</idno><idno type="doi">10.1002/jcla.20070</idno><idno type="wicri:Area/PubMed/Corpus">002635</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002635</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.</title><author><name sortKey="Kogaki, Hiroyuki" sort="Kogaki, Hiroyuki" uniqKey="Kogaki H" first="Hiroyuki" last="Kogaki">Hiroyuki Kogaki</name><affiliation><nlm:affiliation>Research and Development Division, Fujirebio Inc., Tokyo, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Uchida, Yoshiaki" sort="Uchida, Yoshiaki" uniqKey="Uchida Y" first="Yoshiaki" last="Uchida">Yoshiaki Uchida</name></author><author><name sortKey="Fujii, Nobuyuki" sort="Fujii, Nobuyuki" uniqKey="Fujii N" first="Nobuyuki" last="Fujii">Nobuyuki Fujii</name></author><author><name sortKey="Kurano, Yoshihiro" sort="Kurano, Yoshihiro" uniqKey="Kurano Y" first="Yoshihiro" last="Kurano">Yoshihiro Kurano</name></author><author><name sortKey="Miyake, Kazushige" sort="Miyake, Kazushige" uniqKey="Miyake K" first="Kazushige" last="Miyake">Kazushige Miyake</name></author><author><name sortKey="Kido, Yasuji" sort="Kido, Yasuji" uniqKey="Kido Y" first="Yasuji" last="Kido">Yasuji Kido</name></author><author><name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name></author><author><name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name></author><author><name sortKey="Tamashiro, Hiko" sort="Tamashiro, Hiko" uniqKey="Tamashiro H" first="Hiko" last="Tamashiro">Hiko Tamashiro</name></author><author><name sortKey="Ling, Ai Ee" sort="Ling, Ai Ee" uniqKey="Ling A" first="Ai-Ee" last="Ling">Ai-Ee Ling</name></author><author><name sortKey="Okada, Masahisa" sort="Okada, Masahisa" uniqKey="Okada M" first="Masahisa" last="Okada">Masahisa Okada</name></author></analytic><series><title level="j">Journal of clinical laboratory analysis</title><idno type="ISSN">0887-8013</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Monoclonal (immunology)</term><term>Chlorocebus aethiops</term><term>Chromatography</term><term>Coronavirus (immunology)</term><term>DNA, Recombinant</term><term>Escherichia coli</term><term>Immunoenzyme Techniques (instrumentation)</term><term>Immunoenzyme Techniques (methods)</term><term>Mice</term><term>Nucleocapsid (analysis)</term><term>Nucleocapsid (immunology)</term><term>Reproducibility of Results</term><term>Sensitivity and Specificity</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Time Factors</term><term>Vero Cells</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Monoclonal</term></keywords><keywords scheme="MESH" qualifier="analysis" xml:lang="en"><term>Nucleocapsid</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus</term><term>Nucleocapsid</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Immunoenzyme Techniques</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Immunoenzyme Techniques</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Chlorocebus aethiops</term><term>Chromatography</term><term>DNA, Recombinant</term><term>Escherichia coli</term><term>Mice</term><term>Reproducibility of Results</term><term>Sensitivity and Specificity</term><term>Time Factors</term><term>Vero Cells</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A novel severe acute respiratory syndrome-associated coronavirus (SARS-CoV) has been discovered. The detection of both antigens and antibodies in SARS-CoV from human specimens with suspected SARS plays an important role in preventing infection. We developed a novel rapid immunochromatographic test (RICT) based on the sandwich format enzyme immunoassay (EIA) with an all-in-one device for detecting the native nucleocapsid antigen (N-Ag) of SARS-CoV using monoclonal antibodies (MoAbs), which we produced by immunizing recombinant N-Ag to mice. RICT is a qualitative assay for respiratory aspirates and serum specimens. With this assay, a positive result can be judged subjectively by the appearance of a blue line on the device 15 min after the sample is applied. RICT with several pairs of MoAbs showed a high sensitivity for the detection of recombinant N-Ag as well as viral N-Ag of SARS-CoV. rSN122 and rSN21-2 were the best MoAbs for immobilized antibody and enzyme labeling, respectively. With regard to analytical sensitivity, RICT detected N-Ag at 31 pg/mL for recombinant N-Ag, and at 1.99 x 10(2) TCID(50)/mL for SARS-CoV. The specificity of RICT was 100% when 150 human sera and 50 nasopharyngeal aspirates (NSPs) were used. RICT based on an EIA using the rSN122/rSN21-2 pair is a sensitive, specific, and reliable rapid assay for detecting N-Ag in SARS-CoV treated with either heat or Triton X-100.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16025480</PMID><DateCompleted><Year>2007</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0887-8013</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2005</Year></PubDate></JournalIssue><Title>Journal of clinical laboratory analysis</Title><ISOAbbreviation>J. Clin. Lab. Anal.</ISOAbbreviation></Journal><ArticleTitle>Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.</ArticleTitle><Pagination><MedlinePgn>150-9</MedlinePgn></Pagination><Abstract><AbstractText>A novel severe acute respiratory syndrome-associated coronavirus (SARS-CoV) has been discovered. The detection of both antigens and antibodies in SARS-CoV from human specimens with suspected SARS plays an important role in preventing infection. We developed a novel rapid immunochromatographic test (RICT) based on the sandwich format enzyme immunoassay (EIA) with an all-in-one device for detecting the native nucleocapsid antigen (N-Ag) of SARS-CoV using monoclonal antibodies (MoAbs), which we produced by immunizing recombinant N-Ag to mice. RICT is a qualitative assay for respiratory aspirates and serum specimens. With this assay, a positive result can be judged subjectively by the appearance of a blue line on the device 15 min after the sample is applied. RICT with several pairs of MoAbs showed a high sensitivity for the detection of recombinant N-Ag as well as viral N-Ag of SARS-CoV. rSN122 and rSN21-2 were the best MoAbs for immobilized antibody and enzyme labeling, respectively. With regard to analytical sensitivity, RICT detected N-Ag at 31 pg/mL for recombinant N-Ag, and at 1.99 x 10(2) TCID(50)/mL for SARS-CoV. The specificity of RICT was 100% when 150 human sera and 50 nasopharyngeal aspirates (NSPs) were used. RICT based on an EIA using the rSN122/rSN21-2 pair is a sensitive, specific, and reliable rapid assay for detecting N-Ag in SARS-CoV treated with either heat or Triton X-100.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kogaki</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research and Development Division, Fujirebio Inc., Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchida</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kurano</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Miyake</LastName><ForeName>Kazushige</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kido</LastName><ForeName>Yasuji</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kariwa</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Ikuo</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Tamashiro</LastName><ForeName>Hiko</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Ai-Ee</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Lab Anal</MedlineTA><NlmUniqueID>8801384</NlmUniqueID><ISSNLinking>0887-8013</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004274">DNA, Recombinant</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002845" MajorTopicYN="N">Chromatography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004274" MajorTopicYN="N">DNA, Recombinant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019251" MajorTopicYN="N">Nucleocapsid</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>7</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>6</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>7</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16025480</ArticleId><ArticleId IdType="doi">10.1002/jcla.20070</ArticleId><ArticleId IdType="pmc">PMC6807888</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):338-46</Citation><ArticleIdList><ArticleId IdType="pubmed">15170626</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):304-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15030702</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 1975 Aug 7;256(5517):495-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1172191</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2004 Jun;42(6):2629-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15184444</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Chem. 1991 Sep;37(9):1639-44</Citation><ArticleIdList><ArticleId IdType="pubmed">1716538</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Chim Acta. 1997 Nov 6;267(1):87-102</Citation><ArticleIdList><ArticleId IdType="pubmed">9469246</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Feb;75(3):1312-24</Citation><ArticleIdList><ArticleId IdType="pubmed">11152504</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998-9002</Citation><ArticleIdList><ArticleId IdType="pubmed">2461560</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Chem. 2003 Dec;49(12):1976-80</Citation><ArticleIdList><ArticleId IdType="pubmed">14633867</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Chem. 2003 Jun;49(6 Pt 1):953-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12765993</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2004 Mar;11(2):287-91</Citation><ArticleIdList><ArticleId IdType="pubmed">15013977</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2003 Dec;41(12):5781-2</Citation><ArticleIdList><ArticleId IdType="pubmed">14662982</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Lab Anal. 1997;11(6):315-22</Citation><ArticleIdList><ArticleId IdType="pubmed">9406049</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002635 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002635 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:16025480
|texte= Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16025480" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |